Lawrence M. Alleva - Jun 1, 2021 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Director
Signature
/s/ Lawrence M. Alleva
Stock symbol
ADAP
Transactions as of
Jun 1, 2021
Transactions value $
$9,954
Form type
4
Date filed
6/3/2021, 04:31 PM
Next filing
Jun 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADAP Ordinary Shares with a nominal value of GBP0.001 per share Purchase $9.95K +12.6K $0.79 12.6K Jun 1, 2021 Held by Trust F1, F2, F3
holding ADAP Ordinary Shares with a nominal value of GBP0.001 per share 60.2K Jun 1, 2021 Held by Trust F4
holding ADAP Ordinary Shares with a nominal value of GBP0.001 per share 70.6K Jun 1, 2021 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The ordinary shares whose purchase is reported on this line are represented by American Depositary Shares ("ADS") and are held in the form of ADSs by the Lawrence M. Alleva Revocable Trust. Each ADS represents six ordinary shares of Adaptimmune Therapeutics plc.
F2 The 12,600 ordinary shares reported in Column 4 and Column 5 are represented by 2,100 ADSs.
F3 The price reported in Column 4 of $0.79 per ordinary share is derived from the weighted average purchase price paid on June 1, 2021 of $4.745 per ADS divided by six.
F4 The 60,180 ordinary shares reported in Column 5 are represented by 10,030 ADSs. These shares are held in the form of ADSs by the Lawrence M. Alleva Revocable Trust.
F5 The 70,584 ordinary shares reported in Column 5 are represented by 11,764 ADSs. These shares are held in the form of ADSs by Mr. Alleva.